Xcout IntelOruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biopharmaceutical company dedicated to developing novel biologics designed to establish a new treatment standard for chronic skin diseases.
Subscribe to see Oruka Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oruka Therapeutics, Inc. at a glance
Oruka Therapeutics, Inc. is a healthcare company headquartered in Menlo Park, United States. It is publicly listed (ORKA) with a market capitalisation of $5.1B. Xcout tracks 24 named people at Oruka Therapeutics, Inc., including Lawrence Otto Klein (President, Chief Executive Officer & Director).
Oruka Therapeutics, Inc. leadership
- Lawrence Otto KleinPresident, Chief Executive Officer & Director
- Lawrence KleinChief Executive Officer
- Laura SandlerChief Operating Officer
- Joana GoncalvesChief Medical Officer
- Larry Todd EdwardsChief Commercial Officer
- Paul QuinlanGeneral Counsel
18 more named people on record for Oruka Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Oruka Therapeutics, Inc. competitors
A few of Oruka Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nuvig Therapeutics, Inc. is a company headquartered in Palo Alto, California, dedicated to developing novel immune and therapeutic treatments for chronic autoimmune diseases.
SolasCure Limited is a biotechnology research company registered and headquartered in Cambridge, United Kingdom, focused on developing novel wound care solutions.
Ausperbio is a clinical-stage biopharmaceutical company dedicated to transforming hepatitis B virus (HBV) treatment for a cure and advancing oligonucleotide therapeutics.
Elevar Therapeutics is a fully integrated biopharmaceutical company founded in 2019 that focuses on elevating treatment experiences and patient outcomes.
Aldena Therapeutics is a biotechnology company focused on transforming dermatology through novel siRNA-based treatments for skin conditions.
Rinascera Therapeutics, Inc. is a clinical-stage biotechnology company located in Boston, Massachusetts, dedicated to transforming the treatment of rare genetic skin diseases.
Get Oruka Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Oruka Therapeutics, Inc. in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access